nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—EPHA3—central nervous system—Behcet's disease	0.00172	0.00309	CbGeAlD
Dasatinib—HCK—medulla oblongata—Behcet's disease	0.00172	0.00309	CbGeAlD
Dasatinib—RIPK2—cardiac atrium—Behcet's disease	0.00171	0.00308	CbGeAlD
Dasatinib—PKMYT1—brain—Behcet's disease	0.00171	0.00307	CbGeAlD
Dasatinib—TESK1—spinal cord—Behcet's disease	0.00169	0.00304	CbGeAlD
Dasatinib—YES1—eye—Behcet's disease	0.00168	0.00302	CbGeAlD
Dasatinib—SIK1—cardiac atrium—Behcet's disease	0.00167	0.00301	CbGeAlD
Dasatinib—SIK3—central nervous system—Behcet's disease	0.00167	0.003	CbGeAlD
Dasatinib—YES1—retina—Behcet's disease	0.00167	0.003	CbGeAlD
Dasatinib—EPHB3—spinal cord—Behcet's disease	0.00167	0.00299	CbGeAlD
Dasatinib—EPHA4—cardiac atrium—Behcet's disease	0.00165	0.00297	CbGeAlD
Dasatinib—JAK2—skin of body—Behcet's disease	0.00164	0.00296	CbGeAlD
Dasatinib—EPHB2—brain—Behcet's disease	0.00163	0.00292	CbGeAlD
Dasatinib—FYN—skin of body—Behcet's disease	0.00162	0.00292	CbGeAlD
Dasatinib—SRC—eye—Behcet's disease	0.00162	0.00291	CbGeAlD
Dasatinib—RIPK2—medulla oblongata—Behcet's disease	0.00161	0.0029	CbGeAlD
Dasatinib—ZAK—nervous system—Behcet's disease	0.00161	0.0029	CbGeAlD
Dasatinib—LIMK2—spinal cord—Behcet's disease	0.00161	0.00289	CbGeAlD
Dasatinib—SRC—retina—Behcet's disease	0.0016	0.00288	CbGeAlD
Dasatinib—STK35—midbrain—Behcet's disease	0.0016	0.00288	CbGeAlD
Dasatinib—SRMS—brain—Behcet's disease	0.00159	0.00286	CbGeAlD
Dasatinib—CSK—midbrain—Behcet's disease	0.00159	0.00286	CbGeAlD
Dasatinib—FGR—mammalian vulva—Behcet's disease	0.00159	0.00285	CbGeAlD
Dasatinib—LCK—mammalian vulva—Behcet's disease	0.00159	0.00285	CbGeAlD
Dasatinib—MAP3K3—skin of body—Behcet's disease	0.00159	0.00285	CbGeAlD
Dasatinib—EPHA5—nervous system—Behcet's disease	0.00158	0.00284	CbGeAlD
Dasatinib—SIK1—medulla oblongata—Behcet's disease	0.00158	0.00283	CbGeAlD
Dasatinib—LYN—nervous system—Behcet's disease	0.00157	0.00282	CbGeAlD
Dasatinib—HCK—midbrain—Behcet's disease	0.00157	0.00282	CbGeAlD
Dasatinib—EPHA4—medulla oblongata—Behcet's disease	0.00156	0.0028	CbGeAlD
Dasatinib—EPHA8—brain—Behcet's disease	0.00156	0.0028	CbGeAlD
Dasatinib—ZAK—central nervous system—Behcet's disease	0.00155	0.00279	CbGeAlD
Dasatinib—CSK—spinal cord—Behcet's disease	0.00155	0.00279	CbGeAlD
Dasatinib—BMPR1B—nervous system—Behcet's disease	0.00155	0.00278	CbGeAlD
Dasatinib—MAP3K19—nervous system—Behcet's disease	0.00155	0.00278	CbGeAlD
Dasatinib—FMO3—mammalian vulva—Behcet's disease	0.00153	0.00275	CbGeAlD
Dasatinib—HCK—spinal cord—Behcet's disease	0.00153	0.00275	CbGeAlD
Dasatinib—MAP2K5—brainstem—Behcet's disease	0.00153	0.00275	CbGeAlD
Dasatinib—EPHA5—central nervous system—Behcet's disease	0.00152	0.00273	CbGeAlD
Dasatinib—TNK2—nervous system—Behcet's disease	0.00152	0.00273	CbGeAlD
Dasatinib—EPHB6—skin of body—Behcet's disease	0.00151	0.00272	CbGeAlD
Dasatinib—LYN—central nervous system—Behcet's disease	0.00151	0.00272	CbGeAlD
Dasatinib—EPHB4—mammalian vulva—Behcet's disease	0.00151	0.00272	CbGeAlD
Dasatinib—JAK2—mammalian vulva—Behcet's disease	0.0015	0.0027	CbGeAlD
Dasatinib—MAP3K19—central nervous system—Behcet's disease	0.00149	0.00268	CbGeAlD
Dasatinib—BMPR1B—central nervous system—Behcet's disease	0.00149	0.00268	CbGeAlD
Dasatinib—EPHA2—mammalian vulva—Behcet's disease	0.00148	0.00266	CbGeAlD
Dasatinib—FYN—mammalian vulva—Behcet's disease	0.00148	0.00266	CbGeAlD
Dasatinib—STAT5B—brain—Behcet's disease	0.00148	0.00265	CbGeAlD
Dasatinib—RIPK2—midbrain—Behcet's disease	0.00148	0.00265	CbGeAlD
Dasatinib—TNK2—central nervous system—Behcet's disease	0.00146	0.00263	CbGeAlD
Dasatinib—CSF1R—eye—Behcet's disease	0.00145	0.00261	CbGeAlD
Dasatinib—EPHB4—cardiac atrium—Behcet's disease	0.00145	0.0026	CbGeAlD
Dasatinib—MAP3K3—mammalian vulva—Behcet's disease	0.00145	0.0026	CbGeAlD
Dasatinib—MAP4K5—mammalian vulva—Behcet's disease	0.00145	0.0026	CbGeAlD
Dasatinib—RIPK2—spinal cord—Behcet's disease	0.00144	0.00259	CbGeAlD
Dasatinib—JAK2—cardiac atrium—Behcet's disease	0.00144	0.00258	CbGeAlD
Dasatinib—TESK1—nervous system—Behcet's disease	0.00143	0.00256	CbGeAlD
Dasatinib—EPHA2—cardiac atrium—Behcet's disease	0.00142	0.00255	CbGeAlD
Dasatinib—FYN—cardiac atrium—Behcet's disease	0.00142	0.00255	CbGeAlD
Dasatinib—ERBB3—midbrain—Behcet's disease	0.00141	0.00254	CbGeAlD
Dasatinib—SRC—skin of body—Behcet's disease	0.00141	0.00253	CbGeAlD
Dasatinib—SIK1—spinal cord—Behcet's disease	0.00141	0.00253	CbGeAlD
Dasatinib—STK36—nervous system—Behcet's disease	0.0014	0.00252	CbGeAlD
Dasatinib—EPHB3—nervous system—Behcet's disease	0.0014	0.00252	CbGeAlD
Dasatinib—MAP4K5—cardiac atrium—Behcet's disease	0.00138	0.00249	CbGeAlD
Dasatinib—MAP3K3—cardiac atrium—Behcet's disease	0.00138	0.00249	CbGeAlD
Dasatinib—EPHB6—mammalian vulva—Behcet's disease	0.00138	0.00248	CbGeAlD
Dasatinib—ERBB3—spinal cord—Behcet's disease	0.00138	0.00248	CbGeAlD
Dasatinib—TESK1—central nervous system—Behcet's disease	0.00137	0.00247	CbGeAlD
Dasatinib—EPHB4—medulla oblongata—Behcet's disease	0.00136	0.00245	CbGeAlD
Dasatinib—EPHA3—brain—Behcet's disease	0.00136	0.00245	CbGeAlD
Dasatinib—LIMK2—nervous system—Behcet's disease	0.00136	0.00244	CbGeAlD
Dasatinib—KIT—brainstem—Behcet's disease	0.00136	0.00244	CbGeAlD
Dasatinib—JAK2—medulla oblongata—Behcet's disease	0.00135	0.00243	CbGeAlD
Dasatinib—STK36—central nervous system—Behcet's disease	0.00135	0.00243	CbGeAlD
Dasatinib—EPHB3—central nervous system—Behcet's disease	0.00135	0.00243	CbGeAlD
Dasatinib—FYN—medulla oblongata—Behcet's disease	0.00134	0.0024	CbGeAlD
Dasatinib—YES1—mammalian vulva—Behcet's disease	0.00134	0.0024	CbGeAlD
Dasatinib—SIK3—brain—Behcet's disease	0.00133	0.00238	CbGeAlD
Dasatinib—EPHB6—cardiac atrium—Behcet's disease	0.00132	0.00238	CbGeAlD
Dasatinib—STK35—nervous system—Behcet's disease	0.00132	0.00236	CbGeAlD
Dasatinib—CSK—nervous system—Behcet's disease	0.00131	0.00235	CbGeAlD
Dasatinib—LIMK2—central nervous system—Behcet's disease	0.00131	0.00235	CbGeAlD
Dasatinib—MAP4K5—medulla oblongata—Behcet's disease	0.00131	0.00235	CbGeAlD
Dasatinib—MAP3K3—medulla oblongata—Behcet's disease	0.00131	0.00235	CbGeAlD
Dasatinib—HCK—nervous system—Behcet's disease	0.00129	0.00232	CbGeAlD
Dasatinib—PDGFRB—eye—Behcet's disease	0.00129	0.00232	CbGeAlD
Dasatinib—MAPK14—spinal cord—Behcet's disease	0.00128	0.00231	CbGeAlD
Dasatinib—YES1—cardiac atrium—Behcet's disease	0.00128	0.0023	CbGeAlD
Dasatinib—STK35—central nervous system—Behcet's disease	0.00127	0.00228	CbGeAlD
Dasatinib—CSF1R—skin of body—Behcet's disease	0.00126	0.00227	CbGeAlD
Dasatinib—CSK—central nervous system—Behcet's disease	0.00126	0.00226	CbGeAlD
Dasatinib—EPHB6—medulla oblongata—Behcet's disease	0.00125	0.00224	CbGeAlD
Dasatinib—EPHB4—midbrain—Behcet's disease	0.00125	0.00224	CbGeAlD
Dasatinib—HCK—central nervous system—Behcet's disease	0.00124	0.00223	CbGeAlD
Dasatinib—ZAK—brain—Behcet's disease	0.00123	0.00222	CbGeAlD
Dasatinib—SRC—cardiac atrium—Behcet's disease	0.00123	0.00221	CbGeAlD
Dasatinib—FYN—midbrain—Behcet's disease	0.00122	0.00219	CbGeAlD
Dasatinib—EPHB4—spinal cord—Behcet's disease	0.00122	0.00219	CbGeAlD
Dasatinib—JAK2—spinal cord—Behcet's disease	0.00121	0.00217	CbGeAlD
Dasatinib—EPHA5—brain—Behcet's disease	0.00121	0.00217	CbGeAlD
Dasatinib—YES1—medulla oblongata—Behcet's disease	0.00121	0.00217	CbGeAlD
Dasatinib—LYN—brain—Behcet's disease	0.0012	0.00216	CbGeAlD
Dasatinib—MAP3K3—midbrain—Behcet's disease	0.00119	0.00214	CbGeAlD
Dasatinib—MAP4K5—midbrain—Behcet's disease	0.00119	0.00214	CbGeAlD
Dasatinib—FYN—spinal cord—Behcet's disease	0.00119	0.00214	CbGeAlD
Dasatinib—SIK1—nervous system—Behcet's disease	0.00118	0.00213	CbGeAlD
Dasatinib—MAP3K19—brain—Behcet's disease	0.00118	0.00213	CbGeAlD
Dasatinib—BMPR1B—brain—Behcet's disease	0.00118	0.00213	CbGeAlD
Dasatinib—MAP2K5—mammalian vulva—Behcet's disease	0.00118	0.00212	CbGeAlD
Dasatinib—ABL1—brainstem—Behcet's disease	0.00118	0.00212	CbGeAlD
Dasatinib—BTK—brain—Behcet's disease	0.00118	0.00211	CbGeAlD
Dasatinib—EPHA4—nervous system—Behcet's disease	0.00117	0.00211	CbGeAlD
Dasatinib—MAP3K3—spinal cord—Behcet's disease	0.00116	0.00209	CbGeAlD
Dasatinib—MAP4K5—spinal cord—Behcet's disease	0.00116	0.00209	CbGeAlD
Dasatinib—ERBB3—nervous system—Behcet's disease	0.00116	0.00209	CbGeAlD
Dasatinib—TNK2—brain—Behcet's disease	0.00116	0.00208	CbGeAlD
Dasatinib—CSF1R—mammalian vulva—Behcet's disease	0.00115	0.00207	CbGeAlD
Dasatinib—MAP3K2—nervous system—Behcet's disease	0.00115	0.00207	CbGeAlD
Dasatinib—ABL1—eye—Behcet's disease	0.00115	0.00206	CbGeAlD
Dasatinib—KIT—skin of body—Behcet's disease	0.00115	0.00206	CbGeAlD
Dasatinib—SIK1—central nervous system—Behcet's disease	0.00114	0.00205	CbGeAlD
Dasatinib—EPHB6—midbrain—Behcet's disease	0.00114	0.00205	CbGeAlD
Dasatinib—ABL1—retina—Behcet's disease	0.00114	0.00205	CbGeAlD
Dasatinib—MAP2K5—cardiac atrium—Behcet's disease	0.00113	0.00203	CbGeAlD
Dasatinib—EPHA4—central nervous system—Behcet's disease	0.00113	0.00203	CbGeAlD
Dasatinib—PDGFRB—skin of body—Behcet's disease	0.00112	0.00202	CbGeAlD
Dasatinib—ERBB3—central nervous system—Behcet's disease	0.00112	0.00201	CbGeAlD
Dasatinib—EPHB6—spinal cord—Behcet's disease	0.00111	0.002	CbGeAlD
Dasatinib—MAP3K2—central nervous system—Behcet's disease	0.00111	0.00199	CbGeAlD
Dasatinib—CSF1R—cardiac atrium—Behcet's disease	0.0011	0.00198	CbGeAlD
Dasatinib—YES1—midbrain—Behcet's disease	0.0011	0.00198	CbGeAlD
Dasatinib—TESK1—brain—Behcet's disease	0.00109	0.00196	CbGeAlD
Dasatinib—CYP1A1—mouth—Behcet's disease	0.00108	0.00194	CbGeAlD
Dasatinib—MAPK14—nervous system—Behcet's disease	0.00108	0.00194	CbGeAlD
Dasatinib—FGR—nervous system—Behcet's disease	0.00108	0.00193	CbGeAlD
Dasatinib—YES1—spinal cord—Behcet's disease	0.00107	0.00193	CbGeAlD
Dasatinib—EPHB3—brain—Behcet's disease	0.00107	0.00193	CbGeAlD
Dasatinib—STK36—brain—Behcet's disease	0.00107	0.00193	CbGeAlD
Dasatinib—MAP2K5—medulla oblongata—Behcet's disease	0.00107	0.00192	CbGeAlD
Dasatinib—PDGFRA—spinal cord—Behcet's disease	0.00105	0.0019	CbGeAlD
Dasatinib—KIT—mammalian vulva—Behcet's disease	0.00105	0.00188	CbGeAlD
Dasatinib—CSF1R—medulla oblongata—Behcet's disease	0.00104	0.00187	CbGeAlD
Dasatinib—MAPK14—central nervous system—Behcet's disease	0.00104	0.00187	CbGeAlD
Dasatinib—FMO3—nervous system—Behcet's disease	0.00104	0.00187	CbGeAlD
Dasatinib—LIMK2—brain—Behcet's disease	0.00104	0.00186	CbGeAlD
Dasatinib—FGR—central nervous system—Behcet's disease	0.00104	0.00186	CbGeAlD
Dasatinib—SRC—spinal cord—Behcet's disease	0.00103	0.00186	CbGeAlD
Dasatinib—PDGFRB—mammalian vulva—Behcet's disease	0.00102	0.00184	CbGeAlD
Dasatinib—JAK2—nervous system—Behcet's disease	0.00102	0.00183	CbGeAlD
Dasatinib—STK35—brain—Behcet's disease	0.00101	0.00181	CbGeAlD
Dasatinib—EPHA2—nervous system—Behcet's disease	0.00101	0.00181	CbGeAlD
Dasatinib—FYN—nervous system—Behcet's disease	0.001	0.0018	CbGeAlD
Dasatinib—FMO3—central nervous system—Behcet's disease	0.001	0.0018	CbGeAlD
Dasatinib—ABL1—skin of body—Behcet's disease	0.000999	0.0018	CbGeAlD
Dasatinib—CSK—brain—Behcet's disease	0.000999	0.0018	CbGeAlD
Dasatinib—HCK—brain—Behcet's disease	0.000986	0.00177	CbGeAlD
Dasatinib—MAP3K3—nervous system—Behcet's disease	0.000981	0.00176	CbGeAlD
Dasatinib—MAP4K5—nervous system—Behcet's disease	0.000981	0.00176	CbGeAlD
Dasatinib—ABL2—brain—Behcet's disease	0.00098	0.00176	CbGeAlD
Dasatinib—JAK2—central nervous system—Behcet's disease	0.000979	0.00176	CbGeAlD
Dasatinib—PDGFRB—cardiac atrium—Behcet's disease	0.000979	0.00176	CbGeAlD
Dasatinib—MAP2K5—midbrain—Behcet's disease	0.000975	0.00175	CbGeAlD
Dasatinib—CYP1B1—eye—Behcet's disease	0.000973	0.00175	CbGeAlD
Dasatinib—EPHA2—central nervous system—Behcet's disease	0.000968	0.00174	CbGeAlD
Dasatinib—FYN—central nervous system—Behcet's disease	0.000966	0.00174	CbGeAlD
Dasatinib—CSF1R—midbrain—Behcet's disease	0.000951	0.00171	CbGeAlD
Dasatinib—MAP2K5—spinal cord—Behcet's disease	0.000951	0.00171	CbGeAlD
Dasatinib—KIT—medulla oblongata—Behcet's disease	0.000945	0.0017	CbGeAlD
Dasatinib—MAP4K5—central nervous system—Behcet's disease	0.000944	0.0017	CbGeAlD
Dasatinib—MAP3K3—central nervous system—Behcet's disease	0.000944	0.0017	CbGeAlD
Dasatinib—EPHB6—nervous system—Behcet's disease	0.000937	0.00168	CbGeAlD
Dasatinib—CSF1R—spinal cord—Behcet's disease	0.000928	0.00167	CbGeAlD
Dasatinib—RIPK2—brain—Behcet's disease	0.000927	0.00167	CbGeAlD
Dasatinib—PDGFRB—medulla oblongata—Behcet's disease	0.000923	0.00166	CbGeAlD
Dasatinib—ABL1—mammalian vulva—Behcet's disease	0.000911	0.00164	CbGeAlD
Dasatinib—YES1—nervous system—Behcet's disease	0.000906	0.00163	CbGeAlD
Dasatinib—SIK1—brain—Behcet's disease	0.000905	0.00163	CbGeAlD
Dasatinib—EPHB6—central nervous system—Behcet's disease	0.000902	0.00162	CbGeAlD
Dasatinib—EPHA4—brain—Behcet's disease	0.000896	0.00161	CbGeAlD
Dasatinib—PDGFRA—nervous system—Behcet's disease	0.000888	0.0016	CbGeAlD
Dasatinib—ERBB3—brain—Behcet's disease	0.000887	0.00159	CbGeAlD
Dasatinib—MAP3K2—brain—Behcet's disease	0.000879	0.00158	CbGeAlD
Dasatinib—ABL1—cardiac atrium—Behcet's disease	0.000873	0.00157	CbGeAlD
Dasatinib—YES1—central nervous system—Behcet's disease	0.000872	0.00157	CbGeAlD
Dasatinib—SRC—nervous system—Behcet's disease	0.000871	0.00157	CbGeAlD
Dasatinib—KIT—midbrain—Behcet's disease	0.000864	0.00155	CbGeAlD
Dasatinib—PDGFRA—central nervous system—Behcet's disease	0.000855	0.00154	CbGeAlD
Dasatinib—CYP1B1—skin of body—Behcet's disease	0.000846	0.00152	CbGeAlD
Dasatinib—PDGFRB—midbrain—Behcet's disease	0.000844	0.00152	CbGeAlD
Dasatinib—KIT—spinal cord—Behcet's disease	0.000843	0.00152	CbGeAlD
Dasatinib—SRC—central nervous system—Behcet's disease	0.000839	0.00151	CbGeAlD
Dasatinib—MAPK14—brain—Behcet's disease	0.000826	0.00148	CbGeAlD
Dasatinib—PDGFRB—spinal cord—Behcet's disease	0.000823	0.00148	CbGeAlD
Dasatinib—ABL1—medulla oblongata—Behcet's disease	0.000823	0.00148	CbGeAlD
Dasatinib—FGR—brain—Behcet's disease	0.000823	0.00148	CbGeAlD
Dasatinib—MAP2K5—nervous system—Behcet's disease	0.000801	0.00144	CbGeAlD
Dasatinib—FMO3—brain—Behcet's disease	0.000795	0.00143	CbGeAlD
Dasatinib—EPHB4—brain—Behcet's disease	0.000783	0.00141	CbGeAlD
Dasatinib—CSF1R—nervous system—Behcet's disease	0.000782	0.00141	CbGeAlD
Dasatinib—JAK2—brain—Behcet's disease	0.000778	0.0014	CbGeAlD
Dasatinib—MAP2K5—central nervous system—Behcet's disease	0.000772	0.00139	CbGeAlD
Dasatinib—EPHA2—brain—Behcet's disease	0.000768	0.00138	CbGeAlD
Dasatinib—FYN—brain—Behcet's disease	0.000767	0.00138	CbGeAlD
Dasatinib—CSF1R—central nervous system—Behcet's disease	0.000753	0.00135	CbGeAlD
Dasatinib—ABL1—midbrain—Behcet's disease	0.000752	0.00135	CbGeAlD
Dasatinib—MAP3K3—brain—Behcet's disease	0.000749	0.00135	CbGeAlD
Dasatinib—MAP4K5—brain—Behcet's disease	0.000749	0.00135	CbGeAlD
Dasatinib—ABL1—spinal cord—Behcet's disease	0.000734	0.00132	CbGeAlD
Dasatinib—EPHB6—brain—Behcet's disease	0.000716	0.00129	CbGeAlD
Dasatinib—KIT—nervous system—Behcet's disease	0.00071	0.00128	CbGeAlD
Dasatinib—PDGFRB—nervous system—Behcet's disease	0.000694	0.00125	CbGeAlD
Dasatinib—YES1—brain—Behcet's disease	0.000692	0.00124	CbGeAlD
Dasatinib—KIT—central nervous system—Behcet's disease	0.000684	0.00123	CbGeAlD
Dasatinib—PDGFRA—brain—Behcet's disease	0.000679	0.00122	CbGeAlD
Dasatinib—ABCB1—blood vessel—Behcet's disease	0.000671	0.00121	CbGeAlD
Dasatinib—PDGFRB—central nervous system—Behcet's disease	0.000668	0.0012	CbGeAlD
Dasatinib—SRC—brain—Behcet's disease	0.000666	0.0012	CbGeAlD
Dasatinib—ABL1—nervous system—Behcet's disease	0.000618	0.00111	CbGeAlD
Dasatinib—MAP2K5—brain—Behcet's disease	0.000613	0.0011	CbGeAlD
Dasatinib—CYP1A1—skin of body—Behcet's disease	0.000598	0.00108	CbGeAlD
Dasatinib—CSF1R—brain—Behcet's disease	0.000598	0.00107	CbGeAlD
Dasatinib—ABL1—central nervous system—Behcet's disease	0.000595	0.00107	CbGeAlD
Dasatinib—ABCG2—mammalian vulva—Behcet's disease	0.000575	0.00103	CbGeAlD
Dasatinib—CYP1A1—mammalian vulva—Behcet's disease	0.000546	0.000981	CbGeAlD
Dasatinib—KIT—brain—Behcet's disease	0.000543	0.000976	CbGeAlD
Dasatinib—PDGFRB—brain—Behcet's disease	0.00053	0.000953	CbGeAlD
Dasatinib—CYP1B1—nervous system—Behcet's disease	0.000524	0.000941	CbGeAlD
Dasatinib—CYP1A1—cardiac atrium—Behcet's disease	0.000523	0.000939	CbGeAlD
Dasatinib—ABCG2—medulla oblongata—Behcet's disease	0.000519	0.000933	CbGeAlD
Dasatinib—CYP1B1—central nervous system—Behcet's disease	0.000504	0.000906	CbGeAlD
Dasatinib—ABCG2—midbrain—Behcet's disease	0.000474	0.000852	CbGeAlD
Dasatinib—ABL1—brain—Behcet's disease	0.000473	0.000849	CbGeAlD
Dasatinib—ABCG2—spinal cord—Behcet's disease	0.000463	0.000832	CbGeAlD
Dasatinib—CYP1B1—brain—Behcet's disease	0.0004	0.000719	CbGeAlD
Dasatinib—CYP1A1—nervous system—Behcet's disease	0.00037	0.000665	CbGeAlD
Dasatinib—CYP1A1—central nervous system—Behcet's disease	0.000356	0.000641	CbGeAlD
Dasatinib—ABCB1—retina—Behcet's disease	0.000354	0.000636	CbGeAlD
Dasatinib—ABCG2—brain—Behcet's disease	0.000298	0.000536	CbGeAlD
Dasatinib—ABCB1—mammalian vulva—Behcet's disease	0.000283	0.000509	CbGeAlD
Dasatinib—CYP1A1—brain—Behcet's disease	0.000283	0.000509	CbGeAlD
Dasatinib—CYP3A4—nervous system—Behcet's disease	0.000272	0.000488	CbGeAlD
Dasatinib—CYP3A4—central nervous system—Behcet's disease	0.000261	0.00047	CbGeAlD
Dasatinib—ABCB1—medulla oblongata—Behcet's disease	0.000256	0.00046	CbGeAlD
Dasatinib—ABCB1—midbrain—Behcet's disease	0.000234	0.00042	CbGeAlD
Dasatinib—ABCB1—spinal cord—Behcet's disease	0.000228	0.00041	CbGeAlD
Dasatinib—ABCB1—nervous system—Behcet's disease	0.000192	0.000346	CbGeAlD
Dasatinib—ABCB1—central nervous system—Behcet's disease	0.000185	0.000333	CbGeAlD
Dasatinib—ABCB1—brain—Behcet's disease	0.000147	0.000264	CbGeAlD
Dasatinib—STAT5B—Signaling Pathways—APOB—Behcet's disease	0.000123	0.000276	CbGpPWpGaD
Dasatinib—KIT—Immune System—CTLA4—Behcet's disease	0.000122	0.000276	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—CTLA4—Behcet's disease	0.000122	0.000276	CbGpPWpGaD
Dasatinib—LCK—Immune System—ITGAL—Behcet's disease	0.000122	0.000274	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—HLA-B—Behcet's disease	0.000121	0.000274	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—APOA1—Behcet's disease	0.000121	0.000274	CbGpPWpGaD
Dasatinib—KIT—Adaptive Immune System—ICAM1—Behcet's disease	0.000121	0.000273	CbGpPWpGaD
Dasatinib—SRC—Immune System—ITGB2—Behcet's disease	0.000119	0.000269	CbGpPWpGaD
Dasatinib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000119	0.000269	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—APOA1—Behcet's disease	0.000117	0.000263	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—CTLA4—Behcet's disease	0.000116	0.000261	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—HLA-B—Behcet's disease	0.000115	0.00026	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—APOA1—Behcet's disease	0.000115	0.00026	CbGpPWpGaD
Dasatinib—ERBB3—Disease—APOB—Behcet's disease	0.000115	0.00026	CbGpPWpGaD
Dasatinib—PDGFRA—Adaptive Immune System—ICAM1—Behcet's disease	0.000115	0.000259	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CCR1—Behcet's disease	0.000114	0.000258	CbGpPWpGaD
Dasatinib—CSK—Disease—SERPINE1—Behcet's disease	0.000114	0.000256	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—APOB—Behcet's disease	0.000113	0.000255	CbGpPWpGaD
Dasatinib—HCK—Immune System—ICAM1—Behcet's disease	0.000113	0.000255	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—SERPINE1—Behcet's disease	0.000113	0.000254	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CCR1—Behcet's disease	0.000112	0.000252	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CCR1—Behcet's disease	0.00011	0.000248	CbGpPWpGaD
Dasatinib—STAT5B—Disease—SERPINE1—Behcet's disease	0.00011	0.000248	CbGpPWpGaD
Dasatinib—HCK—Disease—APOA1—Behcet's disease	0.00011	0.000247	CbGpPWpGaD
Dasatinib—ABCB1—Allograft Rejection—TNF—Behcet's disease	0.000109	0.000247	CbGpPWpGaD
Dasatinib—CSK—Disease—NOS3—Behcet's disease	0.000108	0.000244	CbGpPWpGaD
Dasatinib—SRC—Immune System—ITGAL—Behcet's disease	0.000108	0.000243	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—NOS3—Behcet's disease	0.000108	0.000243	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000107	0.000241	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—ICAM1—Behcet's disease	0.000106	0.00024	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—HLA-B—Behcet's disease	0.000106	0.00024	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CCR1—Behcet's disease	0.000106	0.000239	CbGpPWpGaD
Dasatinib—STAT5B—Disease—NOS3—Behcet's disease	0.000105	0.000237	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CCR1—Behcet's disease	0.000105	0.000236	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—CTLA4—Behcet's disease	0.000104	0.000235	CbGpPWpGaD
Dasatinib—PDGFRB—Adaptive Immune System—ICAM1—Behcet's disease	0.000103	0.000233	CbGpPWpGaD
Dasatinib—BLK—Immune System—ICAM1—Behcet's disease	0.000102	0.000231	CbGpPWpGaD
Dasatinib—LYN—Immune System—CTLA4—Behcet's disease	0.000102	0.00023	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—HLA-B—Behcet's disease	0.000102	0.00023	CbGpPWpGaD
Dasatinib—FGR—Immune System—ICAM1—Behcet's disease	0.000102	0.00023	CbGpPWpGaD
Dasatinib—ABL1—Immune System—CTLA4—Behcet's disease	0.000102	0.000229	CbGpPWpGaD
Dasatinib—YES1—Immune System—HLA-B—Behcet's disease	0.000101	0.000228	CbGpPWpGaD
Dasatinib—LYN—Adaptive Immune System—ICAM1—Behcet's disease	0.000101	0.000228	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—APOA1—Behcet's disease	0.000101	0.000228	CbGpPWpGaD
Dasatinib—FYN—Immune System—CTLA4—Behcet's disease	0.000101	0.000227	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—APOA1—Behcet's disease	0.0001	0.000226	CbGpPWpGaD
Dasatinib—FYN—Adaptive Immune System—ICAM1—Behcet's disease	9.97e-05	0.000225	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	9.79e-05	0.000221	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—SERPINE1—Behcet's disease	9.78e-05	0.000221	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—SERPINE1—Behcet's disease	9.74e-05	0.00022	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—APOA1—Behcet's disease	9.72e-05	0.000219	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—APOA1—Behcet's disease	9.7e-05	0.000219	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—CTLA4—Behcet's disease	9.69e-05	0.000218	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—SERPINE1—Behcet's disease	9.63e-05	0.000217	CbGpPWpGaD
Dasatinib—JAK2—Immune System—CTLA4—Behcet's disease	9.56e-05	0.000216	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—CXCL8—Behcet's disease	9.56e-05	0.000215	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—HLA-B—Behcet's disease	9.42e-05	0.000212	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—ICAM1—Behcet's disease	9.38e-05	0.000211	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—NOS3—Behcet's disease	9.34e-05	0.000211	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—NOS3—Behcet's disease	9.3e-05	0.00021	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—SERPINE1—Behcet's disease	9.28e-05	0.000209	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—NOS3—Behcet's disease	9.2e-05	0.000207	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CCR1—Behcet's disease	9.17e-05	0.000207	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—SERPINE1—Behcet's disease	9.16e-05	0.000206	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—APOB—Behcet's disease	9.15e-05	0.000206	CbGpPWpGaD
Dasatinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	9.12e-05	0.000206	CbGpPWpGaD
Dasatinib—ERBB3—Disease—APOA1—Behcet's disease	9.12e-05	0.000205	CbGpPWpGaD
Dasatinib—KIT—Immune System—HLA-B—Behcet's disease	9.05e-05	0.000204	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—HLA-B—Behcet's disease	9.04e-05	0.000204	CbGpPWpGaD
Dasatinib—KIT—Disease—APOB—Behcet's disease	9.03e-05	0.000204	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—APOA1—Behcet's disease	8.94e-05	0.000202	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—NOS3—Behcet's disease	8.86e-05	0.0002	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—NOS3—Behcet's disease	8.74e-05	0.000197	CbGpPWpGaD
Dasatinib—HCK—Disease—SERPINE1—Behcet's disease	8.72e-05	0.000196	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—HLA-B—Behcet's disease	8.57e-05	0.000193	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—APOB—Behcet's disease	8.55e-05	0.000193	CbGpPWpGaD
Dasatinib—ABCG2—Transmembrane transport of small molecules—APOA1—Behcet's disease	8.47e-05	0.000191	CbGpPWpGaD
Dasatinib—LCK—Immune System—CTLA4—Behcet's disease	8.38e-05	0.000189	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—APOB—Behcet's disease	8.37e-05	0.000189	CbGpPWpGaD
Dasatinib—HCK—Disease—NOS3—Behcet's disease	8.32e-05	0.000188	CbGpPWpGaD
Dasatinib—LCK—Adaptive Immune System—ICAM1—Behcet's disease	8.3e-05	0.000187	CbGpPWpGaD
Dasatinib—YES1—Immune System—ICAM1—Behcet's disease	8.24e-05	0.000186	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CCR1—Behcet's disease	8.12e-05	0.000183	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—APOB—Behcet's disease	8.07e-05	0.000182	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—SERPINE1—Behcet's disease	8.02e-05	0.000181	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—SERPINE1—Behcet's disease	7.95e-05	0.000179	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—TNF—Behcet's disease	7.89e-05	0.000178	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—HLA-B—Behcet's disease	7.72e-05	0.000174	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—APOB—Behcet's disease	7.7e-05	0.000174	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—SERPINE1—Behcet's disease	7.7e-05	0.000174	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—NOS3—Behcet's disease	7.66e-05	0.000173	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	7.62e-05	0.000172	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—NOS3—Behcet's disease	7.59e-05	0.000171	CbGpPWpGaD
Dasatinib—LYN—Immune System—HLA-B—Behcet's disease	7.56e-05	0.00017	CbGpPWpGaD
Dasatinib—ABL1—Immune System—HLA-B—Behcet's disease	7.52e-05	0.00017	CbGpPWpGaD
Dasatinib—FYN—Immune System—HLA-B—Behcet's disease	7.44e-05	0.000168	CbGpPWpGaD
Dasatinib—FYN—Disease—APOB—Behcet's disease	7.43e-05	0.000167	CbGpPWpGaD
Dasatinib—SRC—Immune System—CTLA4—Behcet's disease	7.41e-05	0.000167	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—NOS3—Behcet's disease	7.36e-05	0.000166	CbGpPWpGaD
Dasatinib—KIT—Immune System—ICAM1—Behcet's disease	7.36e-05	0.000166	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—NOS3—Behcet's disease	7.35e-05	0.000166	CbGpPWpGaD
Dasatinib—SRC—Adaptive Immune System—ICAM1—Behcet's disease	7.35e-05	0.000166	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—APOA1—Behcet's disease	7.24e-05	0.000163	CbGpPWpGaD
Dasatinib—ERBB3—Disease—SERPINE1—Behcet's disease	7.24e-05	0.000163	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—HLA-B—Behcet's disease	7.17e-05	0.000162	CbGpPWpGaD
Dasatinib—KIT—Disease—APOA1—Behcet's disease	7.15e-05	0.000161	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—SERPINE1—Behcet's disease	7.1e-05	0.00016	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—APOB—Behcet's disease	7.08e-05	0.00016	CbGpPWpGaD
Dasatinib—JAK2—Immune System—HLA-B—Behcet's disease	7.07e-05	0.000159	CbGpPWpGaD
Dasatinib—JAK2—Disease—APOB—Behcet's disease	7.06e-05	0.000159	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—ICAM1—Behcet's disease	6.96e-05	0.000157	CbGpPWpGaD
Dasatinib—ERBB3—Disease—NOS3—Behcet's disease	6.91e-05	0.000156	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—NOS3—Behcet's disease	6.78e-05	0.000153	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—APOA1—Behcet's disease	6.77e-05	0.000152	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—CXCL8—Behcet's disease	6.73e-05	0.000152	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—APOA1—Behcet's disease	6.62e-05	0.000149	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—CXCL8—Behcet's disease	6.52e-05	0.000147	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—APOA1—Behcet's disease	6.38e-05	0.000144	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—APOB—Behcet's disease	6.33e-05	0.000143	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—ICAM1—Behcet's disease	6.27e-05	0.000141	CbGpPWpGaD
Dasatinib—LCK—Immune System—HLA-B—Behcet's disease	6.2e-05	0.00014	CbGpPWpGaD
Dasatinib—LCK—Disease—APOB—Behcet's disease	6.18e-05	0.000139	CbGpPWpGaD
Dasatinib—LYN—Immune System—ICAM1—Behcet's disease	6.14e-05	0.000138	CbGpPWpGaD
Dasatinib—ABL1—Immune System—ICAM1—Behcet's disease	6.11e-05	0.000138	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—APOA1—Behcet's disease	6.1e-05	0.000137	CbGpPWpGaD
Dasatinib—FYN—Immune System—ICAM1—Behcet's disease	6.05e-05	0.000136	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	6.03e-05	0.000136	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—APOB—Behcet's disease	5.99e-05	0.000135	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—TNF—Behcet's disease	5.88e-05	0.000133	CbGpPWpGaD
Dasatinib—FYN—Disease—APOA1—Behcet's disease	5.87e-05	0.000132	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—TNF—Behcet's disease	5.85e-05	0.000132	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—ICAM1—Behcet's disease	5.82e-05	0.000131	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	5.79e-05	0.00013	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—TNF—Behcet's disease	5.79e-05	0.00013	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—SERPINE1—Behcet's disease	5.75e-05	0.00013	CbGpPWpGaD
Dasatinib—JAK2—Immune System—ICAM1—Behcet's disease	5.75e-05	0.00013	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—CAT—Behcet's disease	5.68e-05	0.000128	CbGpPWpGaD
Dasatinib—KIT—Disease—SERPINE1—Behcet's disease	5.67e-05	0.000128	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—APOA1—Behcet's disease	5.6e-05	0.000126	CbGpPWpGaD
Dasatinib—JAK2—Disease—APOA1—Behcet's disease	5.58e-05	0.000126	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—TNF—Behcet's disease	5.57e-05	0.000126	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—APOB—Behcet's disease	5.51e-05	0.000124	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—TNF—Behcet's disease	5.5e-05	0.000124	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—NOS3—Behcet's disease	5.49e-05	0.000124	CbGpPWpGaD
Dasatinib—SRC—Immune System—HLA-B—Behcet's disease	5.48e-05	0.000124	CbGpPWpGaD
Dasatinib—SRC—Disease—APOB—Behcet's disease	5.47e-05	0.000123	CbGpPWpGaD
Dasatinib—KIT—Disease—NOS3—Behcet's disease	5.42e-05	0.000122	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	5.4e-05	0.000122	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—APOB—Behcet's disease	5.39e-05	0.000122	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—SERPINE1—Behcet's disease	5.37e-05	0.000121	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—APOB—Behcet's disease	5.28e-05	0.000119	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—SERPINE1—Behcet's disease	5.26e-05	0.000119	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—APOB—Behcet's disease	5.2e-05	0.000117	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—CAT—Behcet's disease	5.17e-05	0.000116	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—NOS3—Behcet's disease	5.13e-05	0.000116	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—SERPINE1—Behcet's disease	5.07e-05	0.000114	CbGpPWpGaD
Dasatinib—LCK—Immune System—ICAM1—Behcet's disease	5.03e-05	0.000113	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—NOS3—Behcet's disease	5.02e-05	0.000113	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—APOB—Behcet's disease	5.02e-05	0.000113	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—APOB—Behcet's disease	5.01e-05	0.000113	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—APOA1—Behcet's disease	5e-05	0.000113	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—APOB—Behcet's disease	4.94e-05	0.000111	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—CXCL8—Behcet's disease	4.9e-05	0.00011	CbGpPWpGaD
Dasatinib—LCK—Disease—APOA1—Behcet's disease	4.89e-05	0.00011	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—CXCL8—Behcet's disease	4.87e-05	0.00011	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	4.86e-05	0.00011	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—NOS3—Behcet's disease	4.84e-05	0.000109	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—SERPINE1—Behcet's disease	4.84e-05	0.000109	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—SERPINE1—Behcet's disease	4.84e-05	0.000109	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—APOA1—Behcet's disease	4.74e-05	0.000107	CbGpPWpGaD
Dasatinib—FYN—Disease—SERPINE1—Behcet's disease	4.66e-05	0.000105	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—NOS3—Behcet's disease	4.62e-05	0.000104	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	4.58e-05	0.000103	CbGpPWpGaD
Dasatinib—SRC—Immune System—ICAM1—Behcet's disease	4.46e-05	0.0001	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—CXCL8—Behcet's disease	4.45e-05	0.0001	CbGpPWpGaD
Dasatinib—FYN—Disease—NOS3—Behcet's disease	4.45e-05	0.0001	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—CXCL8—Behcet's disease	4.45e-05	0.0001	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—SERPINE1—Behcet's disease	4.45e-05	0.0001	CbGpPWpGaD
Dasatinib—JAK2—Disease—SERPINE1—Behcet's disease	4.43e-05	9.99e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—APOA1—Behcet's disease	4.36e-05	9.83e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—APOA1—Behcet's disease	4.33e-05	9.76e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—APOB—Behcet's disease	4.33e-05	9.76e-05	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—CXCL8—Behcet's disease	4.29e-05	9.67e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—APOA1—Behcet's disease	4.27e-05	9.62e-05	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—TNF—Behcet's disease	4.27e-05	9.62e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—NOS3—Behcet's disease	4.25e-05	9.57e-05	CbGpPWpGaD
Dasatinib—JAK2—Disease—NOS3—Behcet's disease	4.23e-05	9.54e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—APOA1—Behcet's disease	4.18e-05	9.42e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—APOA1—Behcet's disease	4.11e-05	9.27e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—SERPINE1—Behcet's disease	3.97e-05	8.95e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—APOA1—Behcet's disease	3.97e-05	8.94e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—APOA1—Behcet's disease	3.96e-05	8.93e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—APOA1—Behcet's disease	3.91e-05	8.81e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—SERPINE1—Behcet's disease	3.88e-05	8.75e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	3.85e-05	8.67e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APOB—Behcet's disease	3.83e-05	8.64e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—NOS3—Behcet's disease	3.79e-05	8.55e-05	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CXCL8—Behcet's disease	3.77e-05	8.49e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—SERPINE1—Behcet's disease	3.76e-05	8.48e-05	CbGpPWpGaD
Dasatinib—LCK—Disease—NOS3—Behcet's disease	3.71e-05	8.35e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CAT—Behcet's disease	3.7e-05	8.34e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—APOB—Behcet's disease	3.59e-05	8.1e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—NOS3—Behcet's disease	3.59e-05	8.09e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CAT—Behcet's disease	3.5e-05	7.88e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—SERPINE1—Behcet's disease	3.44e-05	7.75e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—APOA1—Behcet's disease	3.43e-05	7.72e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APOB—Behcet's disease	3.4e-05	7.65e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—SERPINE1—Behcet's disease	3.39e-05	7.64e-05	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CXCL8—Behcet's disease	3.36e-05	7.58e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—SERPINE1—Behcet's disease	3.32e-05	7.48e-05	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—NOS3—Behcet's disease	3.31e-05	7.45e-05	CbGpPWpGaD
Dasatinib—SRC—Disease—NOS3—Behcet's disease	3.28e-05	7.4e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—SERPINE1—Behcet's disease	3.27e-05	7.36e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—NOS3—Behcet's disease	3.23e-05	7.29e-05	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CXCL8—Behcet's disease	3.18e-05	7.18e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—NOS3—Behcet's disease	3.17e-05	7.14e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—SERPINE1—Behcet's disease	3.14e-05	7.09e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—NOS3—Behcet's disease	3.12e-05	7.03e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—SERPINE1—Behcet's disease	3.1e-05	7e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—APOA1—Behcet's disease	3.03e-05	6.83e-05	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—NOS3—Behcet's disease	3.01e-05	6.78e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—NOS3—Behcet's disease	3e-05	6.77e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—NOS3—Behcet's disease	2.96e-05	6.68e-05	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CXCL8—Behcet's disease	2.87e-05	6.47e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—APOA1—Behcet's disease	2.84e-05	6.41e-05	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CXCL8—Behcet's disease	2.81e-05	6.33e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CAT—Behcet's disease	2.79e-05	6.3e-05	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CXCL8—Behcet's disease	2.77e-05	6.23e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—SERPINE1—Behcet's disease	2.72e-05	6.13e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOB—Behcet's disease	2.71e-05	6.11e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—APOA1—Behcet's disease	2.69e-05	6.05e-05	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CXCL8—Behcet's disease	2.66e-05	6e-05	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CXCL8—Behcet's disease	2.63e-05	5.93e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—NOS3—Behcet's disease	2.6e-05	5.85e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—SERPINE1—Behcet's disease	2.41e-05	5.43e-05	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CXCL8—Behcet's disease	2.3e-05	5.19e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—NOS3—Behcet's disease	2.3e-05	5.18e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CAT—Behcet's disease	2.23e-05	5.03e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOB—Behcet's disease	2.16e-05	4.88e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—NOS3—Behcet's disease	2.15e-05	4.86e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—APOA1—Behcet's disease	2.15e-05	4.84e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CXCL8—Behcet's disease	2.04e-05	4.59e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—NOS3—Behcet's disease	2.04e-05	4.59e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CAT—Behcet's disease	1.72e-05	3.88e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—APOA1—Behcet's disease	1.71e-05	3.86e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOB—Behcet's disease	1.67e-05	3.77e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—NOS3—Behcet's disease	1.63e-05	3.66e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—APOA1—Behcet's disease	1.32e-05	2.98e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—NOS3—Behcet's disease	1.3e-05	2.93e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—NOS3—Behcet's disease	1e-05	2.26e-05	CbGpPWpGaD
